Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD
Conditions: Meibomian Gland Dysfunction; Blepharitis; Demodex Infestation Interventions: Drug: TP-03; Drug: TP-03 Vehicle Sponsor: Tarsus Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2022 Category: Research Source Type: clinical trials
Treatment of Blepharitis With Povidone-Iodine 1%
Condition: Anterior Blepharitis Interventions: Drug: Povidone-Iodine 1 % Topical Solution; Drug: Eyelid cleansing wipes Sponsor: Shaare Zedek Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2021 Category: Research Source Type: clinical trials